Australia approves Iovance’s Amtagvi for advanced melanoma

Markets Investing.com By Investing.com 03 Jun 2026 20:18 1 min read

Australia approves Iovance’s Amtagvi for advanced melanoma

Australia approves Iovance’s Amtagvi for advanced melanoma

Australia approves Iovance’s Amtagvi for advanced melanoma

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.